0001104659-24-033132.txt : 20240311 0001104659-24-033132.hdr.sgml : 20240311 20240311200028 ACCESSION NUMBER: 0001104659-24-033132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SELICK HAROLD E CENTRAL INDEX KEY: 0001287233 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 24739838 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm248535-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-07 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001287233 SELICK HAROLD E C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 1 0 0 0 0 Common Stock 2024-03-07 4 M 0 6490 1.89 A 27996 D Stock Option (right to buy) 1.89 2024-03-07 4 M 0 6490 0.00 D 2024-10-22 Common Stock 6490 0 D The stock option is fully vested. /s/ Matthew Gosling, Attorney-in-Fact for Harold E. Selick 2024-03-11